NCT03482128

Brief Summary

Implementing coagulation management algorithms based on Point-of-care (POC) testing devices such as thromboelastography (TEG) or rotational thromboelastometry (ROTEM) have been shown to reduce transfusion rates and the occurrence of adverse patient outcomes. Apart from the TEG and ROTEM, another viscoelastic POC measurement technique, the SONOCLOT, can be easily used at the bedsite. However Information regarding a SONOCLOT based coagulation management algorithm however is lacking. Transfusion rates of allogeneic blood products (Red blood cells = RBC, Fresh frozen plasma = FFP, Platelet concentrates = PLT) and patient adverse outcomes in two cohorts before and after the implementation of a SONOCLOT based coagulation management algorithm were evaluated on an observational basis in 1754 patients undergoing different types of cardiac surgery. The effect of the cohort and 19 predictors on transfusion was assessed by relative R2-values obtained by bootstrapping and a hurdle regression model, comprising a binomial and a Poisson count component. Association of predictors with post-operative outcomes was assessed with a logistic regression model.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,754

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2015

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 8, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 29, 2018

Completed
Last Updated

May 18, 2018

Status Verified

May 1, 2018

Enrollment Period

5 years

First QC Date

March 8, 2018

Last Update Submit

May 15, 2018

Conditions

Keywords

transfusioncoagulationcardiac surgery

Outcome Measures

Primary Outcomes (1)

  • Transfusion requirement

    RBC-Red Blood Cells (units), FFP-Fresh Frozen Plasma (units), PLT-Platelets (units)

    Postoperative hospital stay; on average 8 days

Secondary Outcomes (2)

  • Postoperative complications

    Postoperative hospital stay; on average 8 days

  • Mortality

    Postoperative hospital stay; on average 8 days

Study Arms (2)

preAlgorithm

Standard coagulation management of patients undergoing cardiac surgery

Device: Standard coagulation management

postAlgorithm

Coagulation management guided by SONOCLOT of patients undergoing cardiac surgery

Device: Coagulation management guided by SONOCLOT

Interventions

Application of blood products guided by SONOCLOT measurements

postAlgorithm

Application of blood products based on clinical experience of the anesthesiologist in charge

preAlgorithm

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing cardiac surgery at the Triemli City Hospital

You may qualify if:

  • Patients undergoing cardiac surgery at the Triemli City Hospital
  • Coronary artery bypass grafting
  • Valve intervention (Aortic/Mitral/Tricuspid)
  • Aortic surgery
  • Time period before implementation of a coagulation management guided by SONOCLOT
  • Time period after implementation of a coagulation management guided by SONOCLOT

You may not qualify if:

  • Time period during implementation of a coagulation management guided by SONOCLOT
  • Missing data in data base

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Triemli City Hospital

Zurich, 8063, Switzerland

Location

Related Publications (3)

  • Serraino GF, Murphy GJ. Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis. Br J Anaesth. 2017 Jun 1;118(6):823-833. doi: 10.1093/bja/aex100.

    PMID: 28475665BACKGROUND
  • Deppe AC, Weber C, Zimmermann J, Kuhn EW, Slottosch I, Liakopoulos OJ, Choi YH, Wahlers T. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res. 2016 Jun 15;203(2):424-33. doi: 10.1016/j.jss.2016.03.008. Epub 2016 Mar 26.

    PMID: 27363652BACKGROUND
  • Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015 Jul;19(58):1-228, v-vi. doi: 10.3310/hta19580.

    PMID: 26215747BACKGROUND

MeSH Terms

Conditions

Blood Coagulation DisordersThrombosis

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic DiseasesEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Michele Genoni, MD, Prof

    Triemli City Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med

Study Record Dates

First Submitted

March 8, 2018

First Posted

March 29, 2018

Study Start

January 1, 2011

Primary Completion

December 31, 2015

Study Completion

December 31, 2015

Last Updated

May 18, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations